Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Rubin Tuder to Hypertrophy, Right Ventricular

This is a "connection" page, showing publications Rubin Tuder has written about Hypertrophy, Right Ventricular.

 
Connection Strength
 
 
 
0.793
 
  1. Tuder RM, Robinson JC, Graham BB. Fat and cardiotoxicity in hereditary pulmonary hypertension. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):247-9.
    View in: PubMed
    Score: 0.433
  2. Cavasin MA, Demos-Davies KM, Schuetze KB, Blakeslee WW, Stratton MS, Tuder RM, McKinsey TA. Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition. J Transl Med. 2014 Nov 26; 12:314.
    View in: PubMed
    Score: 0.115
  3. Tuder RM, Davis LA, Graham BB. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. Am J Respir Crit Care Med. 2012 Feb 01; 185(3):260-6.
    View in: PubMed
    Score: 0.093
  4. Tuder RM, McGrath S, Voelkel NF, Geraci MW. Oxygen-dependent regulation of pulmonary circulation. Methods Enzymol. 2004; 381:87-106.
    View in: PubMed
    Score: 0.054
  5. Voelkel NF, Tuder R. Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation. Ann N Y Acad Sci. 1994 May 28; 725:104-9.
    View in: PubMed
    Score: 0.028
  6. Dweik RA, Rounds S, Erzurum SC, Archer S, Fagan K, Hassoun PM, Hill NS, Humbert M, Kawut SM, Krowka M, Michelakis E, Morrell NW, Stenmark K, Tuder RM, Newman J. An official American Thoracic Society Statement: pulmonary hypertension phenotypes. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):345-55.
    View in: PubMed
    Score: 0.027
  7. Demura Y, Taraseviciene-Stewart L, Scerbavicius R, Tuder RM, Voelkel NF. N-acetylcysteine treatment protects against VEGF-receptor blockade-related emphysema. COPD. 2004 Apr; 1(1):25-32.
    View in: PubMed
    Score: 0.014
  8. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002 Sep; 283(3):L555-62.
    View in: PubMed
    Score: 0.012
  9. Le Cras TD, Kim DH, Gebb S, Markham NE, Shannon JM, Tuder RM, Abman SH. Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. Am J Physiol. 1999 10; 277(4):L709-18.
    View in: PubMed
    Score: 0.010
  10. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol. 1994 Dec; 11(6):664-75.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)